NewsBenzingaAlvotech Gets FDA Nod For Added US Manufacturing Capacity For Humira Biosimilar SIMLANDI, Doubling Drug Substance Capacity At Reykjavik Site Alvotech Gets FDA Nod For Added US Manufacturing Capacity For Humira Biosimilar SIMLANDI, Doubling Drug Substance Capacity At Reykjavik Site Benzinga 2026.10.05 08:21 (GMT+0) Open on Benzinga Other news BMO Capital Maintains Market Perform on BILL Holdings, Lowers Price Target to $63.25 Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20 Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday BMO Capital Maintains Outperform on Palo Alto Networks, Raises Price Target to $425 BMO Capital Maintains Outperform on Alnylam Pharmaceuticals, Raises Price Target to $293
Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday